MX2014000192A - Proceso para la preparacion de la forma 1 del propionato de fluticasona. - Google Patents

Proceso para la preparacion de la forma 1 del propionato de fluticasona.

Info

Publication number
MX2014000192A
MX2014000192A MX2014000192A MX2014000192A MX2014000192A MX 2014000192 A MX2014000192 A MX 2014000192A MX 2014000192 A MX2014000192 A MX 2014000192A MX 2014000192 A MX2014000192 A MX 2014000192A MX 2014000192 A MX2014000192 A MX 2014000192A
Authority
MX
Mexico
Prior art keywords
fluticasone propionate
preparation
acetone
water
propionate form
Prior art date
Application number
MX2014000192A
Other languages
English (en)
Inventor
Martyn David Ticehurst
Ivan Marziano
Eleftherious Kougoulos
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MX2014000192A publication Critical patent/MX2014000192A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Abstract

La invención se refiere a un proceso novedoso de cristalización para preparar propionato de fluticasona como la forma polimórfica cristalina 1, con tamaño de partícula controlado y adecuado para la micronización. El proceso comprende la etapa de disolver propionato de fluticasona en acetona o en una mezcla de acetona y agua y, después, agregar esta solución a agua o a una mezcla de agua 10 y acetona, haciendo así que el propionato de fluticasona se cristalice a partir de la solución como la forma cristalina.
MX2014000192A 2011-07-08 2012-07-06 Proceso para la preparacion de la forma 1 del propionato de fluticasona. MX2014000192A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161505612P 2011-07-08 2011-07-08
PCT/US2012/045660 WO2013009591A1 (en) 2011-07-08 2012-07-06 Process for the preparation of fluticasone propionate form 1

Publications (1)

Publication Number Publication Date
MX2014000192A true MX2014000192A (es) 2014-04-25

Family

ID=47506422

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014000192A MX2014000192A (es) 2011-07-08 2012-07-06 Proceso para la preparacion de la forma 1 del propionato de fluticasona.
MX2020011330A MX2020011330A (es) 2011-07-08 2014-01-07 Proceso para la preparacion de la forma 1 del propionato de fluticasona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020011330A MX2020011330A (es) 2011-07-08 2014-01-07 Proceso para la preparacion de la forma 1 del propionato de fluticasona.

Country Status (10)

Country Link
US (2) US10370402B2 (es)
EP (1) EP2729480A4 (es)
JP (2) JP2014520848A (es)
KR (3) KR20140048237A (es)
CN (2) CN106977575A (es)
AU (1) AU2012282936B2 (es)
CA (1) CA2840401C (es)
MX (2) MX2014000192A (es)
WO (1) WO2013009591A1 (es)
ZA (1) ZA201309531B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106977575A (zh) * 2011-07-08 2017-07-25 辉瑞股份有限公司 用于制备氟替卡松丙酸酯形式1的方法
CN104350063B (zh) 2012-05-08 2018-01-05 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
US9796750B2 (en) * 2014-02-07 2017-10-24 Mylan Laboratories Ltd. Process for the purification of fluticasone propionate using a ketone solvent and water as anti-solvent
CN111662353A (zh) * 2019-03-05 2020-09-15 上海谷森医药有限公司 一种糠酸氟替卡松晶型1的制备方法
MX2021012364A (es) * 2019-04-10 2022-01-18 Eupraxia Pharmaceuticals Inc Proceso para fabricar cristales de farmacos con la distribucion de tama?o y la morfologia deseadas.
CN110759960B (zh) * 2019-10-30 2021-03-23 山东赛托生物科技股份有限公司 一种丙酸氟替卡松的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1291A (en) 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9925934D0 (en) 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0201400D0 (en) 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
GB0202564D0 (en) 2002-02-04 2002-03-20 Glaxo Group Ltd Process
WO2004001369A2 (en) * 2002-06-20 2003-12-31 Sun Pharmaceutical Industries Limited Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
US7314516B2 (en) * 2004-12-29 2008-01-01 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization device and process
CN106977575A (zh) * 2011-07-08 2017-07-25 辉瑞股份有限公司 用于制备氟替卡松丙酸酯形式1的方法

Also Published As

Publication number Publication date
US20140141247A1 (en) 2014-05-22
CN106977575A (zh) 2017-07-25
CA2840401C (en) 2016-05-17
MX2020011330A (es) 2020-11-24
KR20200117056A (ko) 2020-10-13
EP2729480A1 (en) 2014-05-14
ZA201309531B (en) 2014-08-27
JP2014520848A (ja) 2014-08-25
KR102163368B1 (ko) 2020-10-08
AU2012282936B2 (en) 2016-11-10
CN103649104A (zh) 2014-03-19
KR20140048237A (ko) 2014-04-23
EP2729480A4 (en) 2014-12-31
US10370402B2 (en) 2019-08-06
JP2017031161A (ja) 2017-02-09
KR20190107165A (ko) 2019-09-18
CA2840401A1 (en) 2013-01-17
US20200024298A1 (en) 2020-01-23
AU2012282936A1 (en) 2014-01-16
WO2013009591A1 (en) 2013-01-17

Similar Documents

Publication Publication Date Title
MX2020011330A (es) Proceso para la preparacion de la forma 1 del propionato de fluticasona.
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
MX2015005286A (es) Procedimiento para la preparación de derivados del ácido biliar.
MY173877A (en) Branched 3-phenylpropionic acid derivatives and the use thereof
UA110354C2 (uk) Противірусні сполуки
PL2697218T3 (pl) Sposób wytwarzania związków użytecznych, jako inhibitory SGLT2
IN2013CN09704A (es)
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
EA029539B8 (ru) Фармацевтическая композиция ситаглиптина
ZA201403736B (en) Process for the preparation of sterol derivatives
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2012123482A3 (en) Isoxazolidine derivatives
MX343701B (es) Procedimiento para alquinilar 17-cetoesteroides 16-sustituidos.
WO2012063269A3 (en) Process for preparing iloperidone
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
WO2012123493A9 (en) Isoxazolidine derivatives
IN2013MU03508A (es)
WO2013046233A3 (en) Process for the preparation of octreotide acetate
WO2013008250A3 (en) Crystalline form of retigabine and processes for mixture of retigabine crystalline modifications
MY153904A (en) Method of producing pharmacologically pure crystals
HRP20160767T1 (hr) Postupak za pripremu kristalnog oblika i agomelatina
MX2013010001A (es) Derivados de androstanediol como compuestos reguladores del crecimiento de las plantas.
IN2013MU02133A (es)
EP2785673A4 (en) PROCESS FOR PREPARING POLYHYDROXYSTYLENE COMPOUNDS BY PROTECTING THE CORRESPONDING ETHER

Legal Events

Date Code Title Description
FG Grant or registration